CLS Health Announces Merger with Campbell Family Practice and Ghebranious Internal Medicine Associates

July 17, 2024 9:30 AM

HOUSTON, TX / ACCESSWIRE / July 17, 2024 / CLS Health, a leading physician-owned healthcare group, is excited to announce its merger with Campbell Family Practice and Ghebranious Internal Medicine Associates, a well-respected provider of comprehensive family medical services that has been serving the community for nearly 35 years. This merger significantly enhances CLS Health's service offerings and marks an important milestone in expanding its...

Read more

North American Association of Central Cancer Registries Announces New Executive Director

July 17, 2024 9:00 AM

SPRINGFIELD, IL / ACCESSWIRE / July 17, 2024 / The Board of Directors of the North American Association of Central Cancer Registries is pleased to announce Karen L. Knight, MS as its new Executive Director. Following a nationwide search, Ms. Knight was selected based on her outstanding experience in cancer surveillance and registration, making her uniquely qualified for this leadership position.Karen Knight Headshot of Karen Knight Ms. Knight...

Read more

CrossTx Partners With Artemis Global RPM to Expand Remote Patient Monitoring and Chronic Care Management Nationwide

July 17, 2024 8:00 AM

Transforming Healthcare Delivery With Seamless RPM and CCM IntegrationBOZEMAN, MT / ACCESSWIRE / July 17, 2024 / CrossTx, a leading cloud-based Chronic Care Management (CCM) platform, forms a strategic partnership with Artemis Global RPM to scale and streamline Remote Patient Monitoring (RPM) and CCM programs across the United States. The partnership launched turnkey business solutions, including full-service RPM and CCM programs to manage care...

Read more

Tonix Pharmaceuticals, Set to File an NDA for Tonmya for the Management of Fibromyalgia, is Planning Expected Launch in 2H 2025

July 17, 2024 8:00 AM

With the completion of its final pre-NDA meeting with the FDA, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced it is filing an NDA submission in 2H 2024 and laying plans for the commercial launch of Tonmya™* for the management of fibromyalgia, assuming approval by the FDA in 2H 2025.The fibromyalgia market has not seen a new FDA-approved drug in over 15 years. And now with two drugs making their way through the FDA - Tonix's Tonmya...

Read more

The United States Eventing Association Names Zomedica’s PulseVet(R) as the Official Shock Wave of the USEA

July 17, 2024 6:30 AM

ANN ARBOR, MI / ACCESSWIRE / July 17, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, is honored to announce that the United States Eventing Association, Inc. (USEA), a leading equestrian sports organization, has named PulseVet as the "Official Shock Wave of the USEA" for 2024. As part of its...

Read more

JASCO and Bioz Join Forces for a Second Year to Empower the Scientific Community With Publication Data

July 17, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / July 17, 2024 / Bioz, Inc., a pioneer in AI-driven research solutions, is pleased to announce its collaboration with JASCO, a global leader in providing analytical chromatography and spectroscopy instrumentation for scientific research and development. JASCO's commitment to delivering high-quality systems across various scientific domains aligns strongly with Bioz's mission of enhancing research outcomes through...

Read more

BioNxt Signs Statement of Work with International Contract Research, Development, And Manufacturing Organization for Cladribine ODF Development

July 17, 2024 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report that it has signed a statement of work ("SOW") with a German-based international contract research, development, and manufacturing organization (the "CRDMO"). The SOW is focused on the Company's flagship Cladribine oral dissolvable film ("ODF") development program.The SOW sets out a number of important deliverables, including but not limited...

Read more

GCC Medical Glove Market is Expected to be Worth USD 213.7 Million, Growing at a 2.3% Annual Rate by 2034 | Future Market Insights, Inc.

July 17, 2024 1:25 AM

The GCC Medical Glove Marketvalue in 2019 was USD 152.1 million and it witnessed a year-on-year growth rate of 1.9% in the following five years. The medical glove industry in GCC is estimated to be valued at around USD 170.3 million in 2024.As per the new findings, medical disposable glove sales in GCC are projected to increase at 2.3% CAGR through 2034. Further analysis of the industry reveals the GCC medical glove industry value is expected to...

Read more

Here for Good: Merck's Steadfast Commitment to Health Equity

July 16, 2024 4:52 PM

For Priya Agrawal, health equity has been a lifelong concern and a guiding principle in the work she's done across industries. As a young girl growing up in central London, Agrawal saw firsthand how inequities even within her own extended family could drastically impact health outcomes. "I watched my father's side of the family - who lived in London - live with diabetes, but I watched my mother's side of the family - who lived in North India -...

Read more

Medicus Pharma CEO Dr. Raza Bokhari Announces Updated Phase 2 Clinical Protocol Submission to FDA

July 16, 2024 3:15 PM

The submission features significant updates to the clinical protocol, including enhancements to the supporting Chemistry, Manufacturing, and Controls (CMC), along with detailed stability and sterility information. Furthermore, it addresses the clinical non-hold comments previously received from the FDA, ensuring a robust and thorough response to regulatory feedback.Dr. Bokhari shared with Proactive that the revised Phase 2 clinical protocol...

Read more

Analysis Finds Misinformation About Interchangeable Biosimilars Undermining US Health Policy, Physician Confidence, and Patient Health

July 16, 2024 1:55 PM

WASHINGTON, DC / ACCESSWIRE / July 16, 2024 / The Alliance for Safe Biologic Medicines (ASBM) announces the publication of a paper underscoring the critical role of the FDA's interchangeable biosimilar data requirements in maintaining the safety and efficacy of biosimilar substitutions. Titled "Misinformation about interchangeable biosimilars undermines US health policy, physician confidence, and patient health," the paper discusses the...

Read more

Vituity Cares Foundation Joins Forces With the Magic Johnson Foundation and Justin Carr Wants World Peace Foundation for the 2nd Annual Back-to-School Community Event in LA

July 16, 2024 1:00 PM

Comprehensive Back-to-School Event on Saturday, July 20, 2024, Will Feature Life-Saving Cardiac Screenings Alongside Free Haircuts, Supplies, Meals, and MoreLOS ANGELES, CA / ACCESSWIRE / July 16, 2024 / Vituity Cares Foundation (Vituity Cares), a philanthropic arm of the national physician group Vituity, announced its continued partnership with the Magic Johnson Foundation for the upcoming 2nd Annual Back-to-School event on Saturday, July 20,...

Read more

Global Flavored Empty Capsule Market Set to total USD 667.7 Million by 2034, Spurred by Growing Health Awareness and Rise in Lifestyle-related Ailments | FMI

July 16, 2024 1:00 PM

As per Future Market Insights' latest analysis, the global flavored empty capsule market size is estimated to total USD 349.1 million in 2024. It will record healthy growth, with sales surging at 6.7% CAGR throughout the forecast period. By 2034, the total market valuation is set to reach USD 667.7 million.Multiple factors are anticipated to propel the growth of the flavored empty capsule market during the next ten years. These include high...

Read more

Globally Unique VELA Mammography Chair, Offered by Enable Me, is an Exciting New High-Tech Tool in the Fight Against Breast Cancer

July 16, 2024 11:00 AM

TAMPA, FL / ACCESSWIRE / July 16, 2024 / The technologically-advanced, clinically designed VELA Mammography Chair, offered by Enable Me, a VELA Medical company, is an exciting new tool in the fight against breast cancer that provides a stable base for better imaging, a safer, less stressful exam for the patient, and fewer elbow, shoulder and back injuries suffered by mammographers. "Because we believe women deserve to have access to the very...

Read more

Exclusive Interview With Zafer ElKhatib - Physiowell's Co-Founder: Vision and Values

July 16, 2024 10:50 AM

Zafer's Vision: Transforming Rehabilitation in Dubai with PhysiowellDUBAI, UAE / ACCESSWIRE / July 16, 2024 / Physiowell has established itself as a shining symbol of innovation and excellence within the rehabilitation sector in Dubai. Being one of the young Dubai-based business visionaries, Physiowell's co-founder, Zafer ElKhatib, was instrumental in shaping the company's principles and mission. During an exclusive interview, he revealed his...

Read more

Odyssey Behavioral Healthcare’s 2023 Clinical Outcomes Report Identifies Notable Symptom Improvement From Treatment

July 16, 2024 9:30 AM

BRENTWOOD, TN / ACCESSWIRE / July 16, 2024 / Odyssey Behavioral Healthcare ("Odyssey"), a leading provider of mental health, addiction, and eating disorder treatment services, is proud to announce the release of its 2023 clinical outcomes report earlier this year, identifying significant reduction in client symptomology across its residential treatment programs for mental health, substance use, and eating disorders. New to the 2023 report is the...

Read more

CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series

July 16, 2024 9:15 AM

HOUSTON, TX / ACCESSWIRE / July 16, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals will participate in the Virtual Investor Closing Bell Series on Wednesday, June 17, 2024 at 4:00 PM...

Read more

Health eCareers Announces Launch of 'Vital Signs'

July 16, 2024 9:00 AM

New career-focused magazine helps employers, educators, and brands reach nurses nationwide.NEW YORK, NY / ACCESSWIRE / July 16, 2024 / Health eCareers, the nation's largest healthcare-only recruitment and career network, dedicated to helping healthcare employers attract top talent, is proud to announce the launch of Vital Signs, a new national career-focused magazine designed exclusively for the nursing community. Vital Signs is the only...

Read more

VOESH New York Sets the Bar High with New Multifunctional & Eco-Friendly Gua Sha Bars

July 16, 2024 8:45 AM

NEW YORK, NY / ACCESSWIRE / July 16, 2024 / VOESH New York, the leading clean and vegan body care and wellness brand, is thrilled to announce the launch of its new Gua Sha Cleansing and Shampoo Bars. These personal care bars are designed to elevate shower routines, combining the traditional practice of Gua Sha with modern skincare innovation for a better way to wash. Developed with 100% vegan and 97+% natural-origin ingredients, these bars offer...

Read more

Avant Brands Announces $3.9 Million Private Placement of Unsecured Convertible Debenture Units

July 16, 2024 7:30 AM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, today announced the terms of the proposed non-brokered private placement of unsecured convertible debenture units (the "Convertible Debenture Units") at a price of $1,000 per Convertible Debenture Unit (the "Purchase Price") for gross proceeds of up to $3,900,000 (the "Private Placement").Each...

Read more